Knight Therapeutics Inc. (GUD.TO) is scheduled to present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 16, 2024.
This pan-American specialty pharmaceutical company is focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com